Clinical trial
Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic…
NCT00238225 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00238225 |
|---|---|
| Title | Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors |
| Official title | A Phase I Study of Oral Calcitriol in Combination With Ketoconazole in Refractory Advanced Malignancies |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, dexamethasone, ketoconazole |
| Enrollment | 15 |
| Start date | Nov 1, 2004 |
| Primary completion | Jun 1, 2006 |
| First posted | Oct 13, 2005 |
| Last update posted | Jan 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: